Form 4 holding
Director, Other*, 10%+ Owner
ROCKET PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 18,188,457
- Estimated value
- $56,475,158
- Report date
- 19 Sep 2025
- Price
- $3.10
- Ownership
- Indirect
RTW INVESTMENTS, LP - Director, Other*, 10%+ Owner at ROCKET PHARMACEUTICALS, INC.
Issuer-level insider activity
- Role
- Director, Other*, 10%+ Owner
- Issuer ticker
- RCKT, RCKTW on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by RTW INVESTMENTS, LP since 12 Sep 2025
Reported holdings for RTW INVESTMENTS, LP in ROCKET PHARMACEUTICALS, INC.
Form 4 holding
Director, Other*, 10%+ Owner
ROCKET PHARMACEUTICALS, INC.
- Security class
- Pre-funded Warrant (right to buy)
- Shares / value
- 3,526,955
- Estimated value
- $44,051,668
- Report date
- 12 Dec 2024
- Price
- $12.49
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, Other*, 10%+ Owner
ROCKET PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 47,667
- Estimated value
- $159,684
- Report date
- 19 Sep 2025
- Price
- $3.35
- Ownership
- Direct
Form 4 holding
Director, Other*, 10%+ Owner
ROCKET PHARMACEUTICALS, INC.
- Security class
- Equity Swap (obligation to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 19 Sep 2025
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Transaction history for RTW INVESTMENTS, LP in ROCKET PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.